Robert MacLeod
Net worth: - $ as of 2026-08-30
Net worth: - $ as of 2026-08-30
Robert A. MacLeod started working at ADARx Pharmaceuticals, Inc. in 2023.
The current position held is Chief Scientific Officer at ADARx Pharmaceuticals, Inc. since 2023.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-24 | 0 ( -.--% ) | - $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| ADARX PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
| Companies | Position | End |
|---|---|---|
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Chief Tech/Sci/R&D Officer | 2022-11-30 |
| IONIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2021-08-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions